Literature DB >> 6137420

Dopamine-containing small intensely fluorescent cells and sympathetic ganglion function.

N H Neff, F Karoum, M Hadjiconstantinou.   

Abstract

This article reviews some of the neuropharmacology of the dopamine (DA)-containing small intensely fluorescent cells of sympathetic ganglia. The major metabolite of DA found in the ganglia is 3,4-dihydroxyphenylacetic acid (DOPAC). DOPAC content appears to be a direct reflection of DA synthesis. DA synthesis can be enhanced by muscarinic agonists and diminished by muscarinic antagonists. Neuroleptic drugs stimulate DA synthesis in the ganglion, which suggests that a local negative neuronal feedback loop might operate within the ganglion. There may be a correlation between deficient DA synthesis in spontaneous hypertensive rats and the development of hypertension. It is possible that some of the peripheral side effects of drugs that act on dopaminergic neurons in the brain might originate from the drugs' action on peripheral dopaminergic neuronal systems such as the sympathetic ganglion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137420

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  4 in total

1.  Ultrastructural detection of granulated cells in the autonomic ganglia of the rat pancreas.

Authors:  D Baetens; M Vasko; R H Unger; L Orci
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

2.  Comparative morphology, cytochemistry and innervation of chromaffin tissue in vertebrates.

Authors:  D W Scheuermann
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

3.  Dopamine as trace amine in the dorsal root ganglia.

Authors:  J Weil-Fugazza; B Onteniente; G Audet; E Philippe
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

4.  Does endogenous dopamine modulate human sympathetic activity through DA2 receptors?

Authors:  M Mannelli; M L De Feo; M Maggi; A Salvetti; G Giusti; M Serio
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.